Literature DB >> 1717839

Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with Fc epsilon RII and Fc epsilon RI.

A D Keegan1, C Fratazzi, B Shopes, B Baird, D H Conrad.   

Abstract

Three rat monoclonal antibodies specific for mouse IgE (C12B9, 23G3, and B1E3) were established by using monoclonal anti-DNP mouse IgE (mIgE) as immunogen. These antibodies, as well as a fourth, (R1E4) were characterized. It was found that one antibody (C12B9) recognizes an allotypic determinant (Igh-7a) found on the C epsilon chain of mIgE. Antibody cross-blocking studies and epitope mapping studies using recombinant mIgE indicated that 3 antibodies (C12B9, R1E4 and 23G3) were directed against the C epsilon 3 domain while one (B1E3) was directed against the C epsilon 4 domain. A highly specific sandwich RIA for mIgE was developed using these antibodies. Use of these monoclonal anti-mIgE antibodies in conjunction with recombinant chimeric mIgE-human IgG1 molecules, demonstrated that the C epsilon 3 domain is important in the binding of mIgE to the murine B cell Fc epsilon RII as well as to the murine mast cell F epsilon RI. The presence of the C epsilon 4 domain influenced the binding of the recombinant IgE to the Fc epsilon RII; in contrast to the C epsilon 4 domain had no effect on binding to the Fc epsilon RI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717839     DOI: 10.1016/0161-5890(91)90030-n

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Detection of true IgE-expressing mouse B lineage cells.

Authors:  Michael P Gallagher; Akritee Shrestha; Jennifer M Magee; Duane R Wesemann
Journal:  J Vis Exp       Date:  2014-12-01       Impact factor: 1.355

2.  The Il9 CNS-25 Regulatory Element Controls Mast Cell and Basophil IL-9 Production.

Authors:  Amina Abdul Qayum; Byunghee Koh; Rebecca K Martin; Blake T Kenworthy; Rakshin Kharwadkar; Yongyao Fu; Wenting Wu; Daniel H Conrad; Mark H Kaplan
Journal:  J Immunol       Date:  2019-07-26       Impact factor: 5.422

3.  Metalloprotease inhibitor-mediated inhibition of mouse immunoglobulin production.

Authors:  M A Kilmon; R J Mayer; L A Marshall; D H Conrad
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

4.  IgE regulates T helper cell differentiation through FcgammaRIII mediated dendritic cell cytokine modulation.

Authors:  Sarah E Blink; Yang-Xin Fu
Journal:  Cell Immunol       Date:  2010-05-04       Impact factor: 4.868

5.  Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.

Authors:  Cassandra E Smith; Todd N Eagar; Jack L Strominger; Stephen D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

6.  Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.

Authors:  Takayuki Ota; Miyo Aoki-Ota; Bao Hoa Duong; David Nemazee
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro.

Authors:  A M Dvorak; R A Seder; W E Paul; E S Morgan; S J Galli
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  FcRn-mediated intestinal absorption of IgG anti-IgE/IgE immune complexes in mice.

Authors:  S Paveglio; L Puddington; E Rafti; A P Matson
Journal:  Clin Exp Allergy       Date:  2012-12       Impact factor: 5.018

9.  Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.

Authors:  M C Cook; H Körner; D S Riminton; F A Lemckert; J Hasbold; M Amesbury; P D Hodgkin; J G Cyster; J D Sedgwick; A Basten
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

10.  Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation.

Authors:  Hyung-Sik Kang; Sarah E Blink; Robert K Chin; Youjin Lee; Oliver Kim; Joel Weinstock; Thomas Waldschmidt; Daniel Conrad; Bohao Chen; Julian Solway; Anne I Sperling; Yang-Xin Fu
Journal:  J Exp Med       Date:  2003-11-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.